Published in Acta Trop on September 11, 2008
Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol (2010) 2.10
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl Trop Dis (2008) 1.54
Schistosomiasis vaccines. Hum Vaccin (2011) 1.23
The Human Hookworm Vaccine. Vaccine (2013) 1.05
Fatty acid- and retinoid-binding proteins have distinct binding pockets for the two types of cargo. J Biol Chem (2009) 1.02
Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies. PLoS Negl Trop Dis (2016) 1.01
Immunology of human schistosomiasis. Parasite Immunol (2014) 0.99
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog (2014) 0.93
Novel therapeutic and prevention approaches for schistosomiasis: review. J Adv Res (2012) 0.89
Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control. Br J Pharmacol (2014) 0.86
Bilharzia: Pathology, Diagnosis, Management and Control. Trop Med Surg (2013) 0.86
Serological screening of the Schistosoma mansoni adult worm proteome. PLoS Negl Trop Dis (2014) 0.85
Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases. Front Genet (2014) 0.84
Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine. Front Immunol (2015) 0.83
Structural and binding properties of two paralogous fatty acid binding proteins of Taenia solium metacestode. PLoS Negl Trop Dis (2012) 0.82
Schistosomiasis vaccines: where do we stand? Parasit Vectors (2016) 0.81
Development of a schistosomiasis vaccine. Expert Rev Vaccines (2016) 0.79
Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model. BMC Infect Dis (2015) 0.78
Still hope for schistosomiasis vaccine. Hum Vaccin Immunother (2015) 0.78
Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis. Clin Exp Immunol (2012) 0.75
The cancer/testis genes: review, standardization, and commentary. Cancer Immun (2004) 4.78
Long-range heterogeneity at the 3' ends of human mRNAs. Genome Res (2002) 3.91
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res (2006) 3.72
High-throughput SELEX SAGE method for quantitative modeling of transcription-factor binding sites. Nat Biotechnol (2002) 3.04
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res (2005) 2.73
Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A (2008) 2.66
Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing. Proc Natl Acad Sci U S A (2003) 2.64
Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc Natl Acad Sci U S A (2009) 2.57
An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res (2005) 2.39
Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas. Proc Natl Acad Sci U S A (2005) 2.38
Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. J Bacteriol (2005) 2.15
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res (2008) 2.14
MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res (2007) 2.08
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res (2006) 2.03
Sequence-based cancer genomics: progress, lessons and opportunities. Nat Rev Genet (2003) 2.01
Nineteen additional unpredicted transcripts from human chromosome 21. Genomics (2002) 1.80
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A (2006) 1.77
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J Exp Med (2007) 1.73
The genome sequence of the gram-positive sugarcane pathogen Leifsonia xyli subsp. xyli. Mol Plant Microbe Interact (2004) 1.65
CT-X antigen expression in human breast cancer. Proc Natl Acad Sci U S A (2009) 1.51
Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Proc Natl Acad Sci U S A (2005) 1.39
Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein. Cancer Immun (2005) 1.26
Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem (2010) 1.22
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immun (2007) 1.21
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome. Genes Chromosomes Cancer (2006) 1.19
Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia (2005) 1.13
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer (2005) 1.12
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2. Cancer Immun (2006) 1.10
Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma. PLoS One (2011) 1.09
Oncogenomics and the development of new cancer therapies. Nature (2004) 1.06
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene (2004) 1.02
Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biol (2010) 1.01
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun (2004) 1.00
The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Clin Cancer Res (2004) 0.98
Less DeltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res (2004) 0.96
ORESTES are enriched in rare exon usage variants affecting the encoded proteins. C R Biol (2004) 0.95
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6). Cancer Immun (2006) 0.95
Cancer-testis (CT) antigen expression in medulloblastoma. Cancer Immun (2008) 0.94
Low-stringency single specific primer PCR for identification of Leptospira. J Med Microbiol (2003) 0.93
Effects of CT-Xp gene knock down in melanoma cell lines. Oncotarget (2013) 0.93
Cancer/testis (CT) antigens are expressed in fetal ovary. Cancer Immun (2007) 0.92
A transcript finishing initiative for closing gaps in the human transcriptome. Genome Res (2004) 0.89
HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma. Nucleic Acids Res (2006) 0.89
Identification of unannotated exons of low abundance transcripts in Drosophila melanogaster and cloning of a new serine protease gene upregulated upon injury. BMC Genomics (2007) 0.88
Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual. Nucleic Acids Res (2011) 0.88
Differential evolution of MAGE genes based on expression pattern and selection pressure. PLoS One (2012) 0.87
Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet Mol Res (2006) 0.87
Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci U S A (2006) 0.87
hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol (2002) 0.84
The use of Open Reading frame ESTs (ORESTES) for analysis of the honey bee transcriptome. BMC Genomics (2004) 0.84
The common mitochondrial DNA deletion deltamtDNA(4977): shedding new light to the concept of a tumor suppressor mutation. Med Hypotheses (2003) 0.83
Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14. Parasite Immunol (2003) 0.83
Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis. Genomics (2009) 0.82
Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA. ACS Chem Biol (2011) 0.81
In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells. Genomics (2002) 0.80
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches. Cancer Immunol Res (2013) 0.79
Analysis of the first and second internal transcribed spacer sequences of the ribosomal DNA in Biomphalaria tenagophila complex (Mollusca: Planorbidae). Mem Inst Oswaldo Cruz (2004) 0.78
Identification of 9 novel transcripts and two RGSL genes within the hereditary prostate cancer region (HPC1) at 1q25. Gene (2003) 0.78
Polymerase chain reaction and restriction fragment length polymorphism of cytocrome oxidase subunit I used for differentiation of Brazilian Biomphalaria species intermediate host of Schistosoma mansoni. Mem Inst Oswaldo Cruz (2002) 0.78
Insights on PRAME and osteosarcoma by means of gene expression profiling. J Orthop Sci (2011) 0.77
Association of CYP3A4 genotype with detection of Vgamma/Jbeta trans-rearrangements in the peripheral blood leukocytes of pediatric cancer patients undergoing chemotherapy for ALL. Leuk Res (2004) 0.76
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis (2003) 0.76
Development and application of a multiplex PCR procedure for the detection of DNA methylation in colorectal cancer. Oncol Rep (2005) 0.76
Human gene discovery through experimental definition of transcribed regions of the human genome. Curr Opin Chem Biol (2002) 0.76
Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells. PLoS One (2013) 0.75
Collaborative research networks work. J Clin Invest (2003) 0.75
Commentary on Samuel Broder's, Stephen Hoffman's and Peter Hotez's article in EMBO reports, September 2002. EMBO Rep (2002) 0.75
Identification and complete sequencing of novel human transcripts through the use of mouse orthologs and testis cDNA sequences. Genet Mol Res (2004) 0.75
Closure of rRNA related gaps in the Chromobacterium violaceum genome with the PCR-assisted contig extension (PACE) protocol. Genet Mol Res (2004) 0.75